Intra-Myocardial Injection of A Novel Thermosensitive Hydrogel Inhibits Post-Infarct Heart Failure in Rats

Ying Wen,Xiao-Yan Li,Ze-Yong Li,Meng-Long Wang,Xian-Zheng Zhang,Xue-Jun Jiang
DOI: https://doi.org/10.1161/res.119.suppl_1.216
IF: 23.213
2016-01-01
Circulation Research
Abstract:Intra-myocardial injection of hydrogel after myocardial infarction (MI) has been confirmed for preventing post-infarct ventricular remodeling (VR) in numerous studies. Meanwhile, VR or existed heart failure (HF) symptoms of patients with MI was improved after intra-myocardial injection of hydrogels in recent clinical trials. However, whether the injection of hydrogel immediately after MI can prevent post-infarct HF in a long follow-up period is unclear. In present study, MI was induced by permanent coronary artery ligation in SD rats. Immediately, 100μl Dex-PCL-HEMA/ PNIPAAm (DPHP) hydrogel solution was injected into the infarct border myocardium of experimental rats, while phosphate-buffered saline (PBS) was employed in control group. Twelve weeks later, compared with PBS group (n=11), echocardiography and hemodynamics showed left ventricle dilatation was attenuated (end-diastolic diameter 9.30±0.73 mm vs 10.74±0.57 mm, p <0.01) and cardiac function was improved (+dp/dt 12351±1158 mmHg/s vs 9488±695 mmHg/s, p <0.01) in hydrogel group (n=11). Serum brain natriuretic peptide (107.74±18.21 pg/ml vs 132.17±20.62 pg/ml, p <0.05) and cardiac aldosterone production of hydrogel group was suppressed, and so did pulmonary congestion. Histological analysis indicated thicker scar, smaller infarct size, diminished cardiac fibrosis (collagen volume fraction 21.74±3.13% vs 33.38±3.08%, p <0.01) and hypertrophy in hydrogel group. Higher Col3α1 mRNA (27.32±0.71 vs 14.29±1.37, p <0.01) in infarct zone but lower Col3α1 mRNA (0.97±0.12 vs 9.06±1.04, p <0.01) and ANP mRNA (10.03±1.49 vs 24.74±2.40, p <0.01) in non-infarct zone (NIZ) were detected by RT-PCR in hydrogel group. These data proves that the intra-myocardial injection of DPHP hydrogel immediately after MI can improve cardiac function including diastolic function, decrease infarct size, and enhance fibrotic healing in the infarct area. On the other hand, this treatment suppresses reactive fibrosis and hypertrophy in NIZ and thus delays post-infarct VR and prevents HF. DPHP hydrogel implantation immediately after MI is an effective strategy to prevent abnormal cardiac remodeling and have a long term beneficial effect even after it has been biodegraded.
What problem does this paper attempt to address?